Tantalizing Therapeutics in Bronchopulmonary Dysplasia is a concise reference that provides an overview of emerging concepts in the understanding of lung development and injury from a molecular and cellular point-of-view, including exciting pathways that are paving the way for new options to prevent or treat Bronchopulmonary Dysplasia (BPD. The book's chapters are written by experts who are at the forefront BPD research. Coverage includes chapters on exosomes, stem cells and miRs, as well as a section on new discoveries in BPD research with translational potential. This is a must-have reference for researchers, physicians and trainees working on BPD, lung developmental biology, and more. Includes discussions on which aspects of the bench research in Bronchopulmonary Dysplasia are the most promising areasOffers insights into the latest research being conducted that could potentially move to the bassinet (in the NICU)Contains evidence-based summaries and informed opinions about existing therapies INDICE: 1. Corticosteroids: Inhaled and systemic state-of-the art for prevention of BPD 2. Less invasive surfactant therapy for BPD 3. Use of caffeine for prevention of BPD4. Stem cells in the treatment of BPD 5. Exosomes in the therapy of BPD: An update 6. IL-1RA in the therapy of BPD: An update7. Club cell protein (CC16) in the prevention of acute and chronic lung injury in the newborn 8. Miscellaneous anti-inflammatory agents in the prevention and treatment of BPD 9. miRs - mere hype or master regulators towards a cure for BPD?
- ISBN: 978-0-12-818987-0
- Editorial: Academic Press
- Encuadernacion: Rústica
- Páginas: 250
- Fecha Publicación: 01/06/2020
- Nº Volúmenes: 1
- Idioma: Inglés